Polaryx Therapeutics, Inc. Earnings Per Share (Basic)
Polaryx Therapeutics, Inc. (PLYX) reported Earnings Per Share (Basic) of -$0.03 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Polaryx Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.03.
- Polaryx Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.05.
- Polaryx Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.02.
- Polaryx Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-03-31 was -$0.11.
- Polaryx Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$0.20.
- Polaryx Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$0.89.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|
| 2026-06-30 | -$0.03 10-Q · filed 2026-08-13 | -$0.08 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$0.05 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | -$0.20 10-K · filed 2026-03-24 | ||
| 2025-06-30 | -$0.02 10-Q · filed 2026-08-13 | -$0.14 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$0.11 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | -$0.89 10-K · filed 2026-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |